[1]
|
Yang, W.-J., Zhao, H.-P., Yu, Y., Wang, J.-H., Guo, L., Liu, J.-Y., Pu, J. and Lv, J. (2023) Updates on Global Epidemiology, Risk and Prognostic Factors of Gastric Cancer. World Journal of Gastroenterology, 29, 2452-2468. https://doi.org/10.3748/wjg.v29.i16.2452
|
[2]
|
Wu, H., Wang, W., Tong, S. and Wu, C. (2015) Nucleostemin Regulates Proliferation and Migration of Gastric Cancer and Correlates with Its Malignancy. International Journal of Clinical and Experimental Medicine, 8, 17634-17643.
|
[3]
|
Mai, M., Takahashi, Y., Fujimoto, T. and Omote, K. (1994) [Neoadjuvant Chemotherapy for Far-Advanced Gastric Carcinoma]. Japanese Journal of Cancer and Chemotherapy, 21, 431-439.
|
[4]
|
Crookes, P., Leichman, C.G., Leichman, L., et al. (1997) Systemic Chemotherapy for Gastric Carcinoma Followed by Postoperative Intraperitoneal Therapy: A Final Report. Cancer, 79, 1767-1775. https://doi.org/10.1002/(SICI)1097-0142(19970501)79:9<1767::AID-CNCR19>3.0.CO;2-W
|
[5]
|
Gianni, L., Panzini, I., Tassinari, D., et al. (2001) Meta-Analyses of Randomized Trials of Adjuvant Chemotherapy in Gastric Cancer. Annals of Oncology, 12, 1179-1181. https://doi.org/10.1023/A:1011611821258
|
[6]
|
Schuhmacher, C.P., Fink, U., Becker, K., et al. (2001) Neoadjuvant Therapy for Patients with Locally Advanced Gastric Carcinoma with Etoposide, Doxorubicin, and Cisplatinum. Closing Results after 5 Years of Follow-Up. Cancer, 91, 918-927. https://doi.org/10.1002/1097-0142(20010301)91:5<918::AID-CNCR1081>3.0.CO;2-W
|
[7]
|
Mirza, A., Pritchard, S. and Welch, I. (2013) The Postoperative Component of MAGIC Chemotherapy Is Associated with Improved Prognosis Following Surgical Resection in Gastric and Gastrooesophageal Junction Adenocarcinomas. International Journal of Surgical Oncology, 2013, Article ID: 781742. https://doi.org/10.1155/2013/781742
|
[8]
|
Singh, N., Badrun, D. and Ghatage, P. (2020) State of the Art and Up-and-Coming Angiogenesis Inhibitors for Ovarian Cancer. Expert Opinion on Pharmacotherapy, 21, 1579-1590. https://doi.org/10.1080/14656566.2020.1775813
|
[9]
|
Lv, Y., Song, L., Chang, L., et al. (2016) Bevacizumab Followed by Chemotherapy Is Potential Therapy for Gastric Cancer. Journal of Balkan Union of Oncology, 21, 1466-1470.
|
[10]
|
Shah, M.A., Ramanathan, R.K., Ilson, D.H., et al. (2006) Multicenter Phase II Study of Irinotecan, Cisplatin, and Bevacizumab in Patients with Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma. Journal of Clinical Oncology, 24, 5201-5206. https://doi.org/10.1200/JCO.2006.08.0887
|
[11]
|
Li, Y., Wang, C., Xu, M., et al. (2017) Preoperative NLR for Predicting Survival Rate after Radical Resection Combined with Adjuvant Immunotherapy with CIK and Postoperative Chemotherapy in Gastric Cancer. Journal of Cancer Research and Clinical Oncology, 143, 861-871. https://doi.org/10.1007/s00432-016-2330-1
|
[12]
|
Cai, X.-Y., Wang, X.-F., Li, J., et al. (2016) High Expression of CD39 in Gastric Cancer Reduces Patient Outcome Following Radical Resection. Oncology Letters, 12, 4080-4086. https://doi.org/10.3892/ol.2016.5189
|
[13]
|
Andreyev, H.J., Norman, A.R., Oates, J., et al. (1998) Why Do Patients with Weight Loss Have a Worse Outcome When Undergoing Chemotherapy for Gastrointestinal Malignancies? European Journal of Cancer, 34, 503-509. https://doi.org/10.1016/S0959-8049(97)10090-9
|
[14]
|
Thoresen, L., Fjeldstad, I., Krogstad, K., et al. (2002) Nutritional Status of Patients with Advanced Cancer: The Value of Using the Subjective Global Assessment of Nutritional Status as a Screening Tool. Palliative Medicine, 16, 33-42. https://doi.org/10.1191/0269216302pm486oa
|
[15]
|
Rosania, R., Chiapponi, C., Malfertheiner, P., et al. (2016) Nutrition in Patients with Gastric Cancer: An Update. Gastrointestinal Tumors, 2, 178-187. https://doi.org/10.1159/000445188
|
[16]
|
Vergara, N., Montoya, J.E., Luna, H.G., et al. (2013) Quality of Life and Nutritional Status among Cancer Patients on Chemotherapy. Oman Medical Journal, 28, 270-274. https://doi.org/10.5001/omj.2013.75
|
[17]
|
Marin Caro, M.M., Laviano, A. and Pichard, C. (2007) Nutritional Intervention and Quality of Life in Adult Oncology Patients. Clinical Nutrition, 26, 289-301. https://doi.org/10.1016/j.clnu.2007.01.005
|
[18]
|
Lim, S., Brown, J.L., Washington, T.A., et al. (2020) Development and Progression of Cancer Cachexia: Perspectives from Bench to Bedside. Sports Medicine and Health Science, 2, 177-185. https://doi.org/10.1016/j.smhs.2020.10.003
|
[19]
|
Esper, D.H. and Harb, W.A. (2005) The Cancer Cachexia Syndrome: A Review of Metabolic and Clinical Manifestations. Nutrition in Clinical Practice, 20, 369-376. https://doi.org/10.1177/0115426505020004369
|
[20]
|
Heys, S.D., Walker, L.G., Deehan, D.J. and Eremin, O.E. (1998) Serum Albumin: A Prognostic Indicator in Patients with Colorectal Cancer. Journal of the Royal College of Surgeons of Edinburgh, 43, 163-168.
|
[21]
|
Han, K.S. and Hong, S.J. (2014) Serum Alkaline Phosphatase Differentiates Prostate-Specific Antigen Flare from Early Disease Progression after Docetaxel Chemotherapy in Castration-Resistant Prostate Cancer with Bone Metastasis. Journal of Cancer Research and Clinical Oncology, 140, 1769-1776. https://doi.org/10.1007/s00432-014-1710-7
|
[22]
|
Kim, J.M., Kwon, C.H.D., Joh, J.-W., Park, J.B., Ko, J.S., Lee, J.H., Kim, S.J. and Park, C.-K. (2013) The Effect of Alkaline Phosphatase and Intrahepatic Metastases in Large Hepatocellular Carcinoma. World Journal of Surgical Oncology, 11, Article No. 40. https://doi.org/10.1186/1477-7819-11-40
|
[23]
|
Zhang, L. and Gong, Z. (2017) Clinical Characteristics and Prognostic Factors in Bone Metastases from Lung Cancer. Medical Science Monitor, 23, 4087-4094. https://doi.org/10.12659/MSM.902971
|
[24]
|
Haarhaus, M., Brandenburg, V., Kalantar-Zadeh, K., et al. (2017) Alkaline Hosphatase: A Novel Treatment Target for Cardiovascular Disease in CKD. Nature Reviews Nephrology, 13, 429-442. https://doi.org/10.1038/nrneph.2017.60
|
[25]
|
Long, Z.Q., Hua, X., Zhang, W.W., et al. (2019) Prognostic Impact of the Pretreatment Albumin to Alkaline Phosphatase Ratio for Nonmetastatic Breast Cancer Patients. Cancer Management and Research, 11, 4809-4814. https://doi.org/10.2147/CMAR.S200759
|
[26]
|
Chen, B., Dai, D., Tang, H., Chen, X., Ai, X., Huang, X., Wei, W. and Xie, X. (2016) Pre-Treatment Serum Alkaline Phosphatase and Lactate Dehydrogenase as Prognostic Factors in Triple Negative Breast Cancer. Journal of Cancer, 7, 2309-2316. https://doi.org/10.7150/jca.16622
|
[27]
|
Namikawa, T., Ishida, N., Tsuda, S., Fujisawa, K., Munekage, E., Iwabu, J., Munekage, M., Uemura, S., Tsujii, S., Tamura, T., Yatabe, T., Maeda, H., Kitagawa, H., Kobayashi, M. and Hanazaki, K. (2019) Prognostic Significance of Serum Alkaline Phosphatase and Lactate Dehydrogenase Levels in Patients with Unresectable Advanced Gastric Cancer. Gastric Cancer, 22, 684-691. https://doi.org/10.1007/s10120-018-0897-8
|
[28]
|
Rodriguez-Vita, J. and Lawrence, T. (2010) The Resolution of Inflammation and Cancer. Cytokine & Growth Factor Reviews, 21, 61-65. https://doi.org/10.1016/j.cytogfr.2009.11.006
|
[29]
|
Miller-Ocuin, J.L., Liang, X., Boone, B.A., et al. (2019) DNA Released from Neutrophil Extracellular Traps (NETs) Activates Pancreatic Stellate Cells and Enhances Pancreatic Tumor Growth. OncoImmunology, 8, e1605822. https://doi.org/10.1080/2162402X.2019.1605822
|
[30]
|
商安全, 李冬. 中性粒细胞与肿瘤: 是敌是友? [J]. 国际检验医学杂志, 2020, 41(1): 104-110.
|
[31]
|
Cools-Lartigue, J., Spicer, J., McDonald, B., et al. (2013) Neutrophil Extracellular Traps Sequester Circulating Tumor Cells and Promote Metastasis. The Journal of Clinical Investigation, 123, 3446-3458.
|
[32]
|
Pillay, J., Den Braber, I., Vrisekoop, N., et al. (2010) In vivo Labeling with 2H2O Reveals a Human Neutrophil Lifespan of 5.4 Days. Blood, 116, 625-627. https://doi.org/10.1182/blood-2010-01-259028
|
[33]
|
Liang, W. and Ferrara, N. (2016) The Complex Role of Neutrophils in Tumor Angiogenesis and Metastasis. Cancer Immunology Research, 4, 83-91. https://doi.org/10.1158/2326-6066.CIR-15-0313
|
[34]
|
Swierczak, A., Mouchemore, K.A., Hamilton, J.A. and Anderson, R.L. (2015) Neutrophils: Important Contributors to Tumor Progression and Metastasis. Cancer Metastasis Reviews, 34, 735-751. https://doi.org/10.1007/s10555-015-9594-9
|
[35]
|
Ogiya, R., Niikura, N., Kumaki, N., et al. (2016) Comparison of Tumor-Infiltrating Lymphocytes between Primary and Metastatic Tumors in Breast Cancer Patients. Cancer Science, 107, 1730-1735. https://doi.org/10.1111/cas.13101
|
[36]
|
Fang, T., Wang, Y., Yin, X., Zhai, Z., Zhang, Y., Yang, Y., You, Q., Li, Z., Ma, Y., Li, C., Song, H., Shi, H., Zhang, Y., Yu, X., Gao, H., Sun, Y., Xie, R. and Xue, Y. (2020) Diagnostic Sensitivity of NLR and PLR in Early Diagnosis of Gastric Cancer. Journal of Immunology Research, 2020, Article ID: 9146042. https://doi.org/10.1155/2020/9146042
|
[37]
|
Gay, L.J. and Felding-Habermann, B. (2011) Contribution of Platelets to Tumour Metastasis. Nature Reviews Cancer, 11, 123-134. https://doi.org/10.1038/nrc3004
|
[38]
|
Banks, R.E., Forbes, M.A., Kinsey, S.E., et al. (1998) Release of the Angiogenic Cytokine Vascular Endothelial Growth Factor (VEGF) from Platelets: Significance for VEGF Measurements and Cancer Biology. British Journal of Cancer, 77, 956-964. https://doi.org/10.1038/bjc.1998.158
|
[39]
|
Zhou, X., Du, Y., Huang, Z., Xu, J., Qiu, T., Wang, J., Wang, T., Zhu, W. and Liu, P. (2014) Prognostic Value of PLR in Various Cancers: A Meta-Analysis. PLOS ONE, 9, e101119. https://doi.org/10.1371/journal.pone.0101119
|
[40]
|
Cruz-Ramos, M., Del Puerto-Nevado, L., Zheng, B., Lopez-Bajo, R., Cebrian, A., Rodriguez-Remirez, M., Garcia-Garcia, L., Solanes-Casado, S. and Garcia-Foncillas, J. (2019) Prognostic Significance of Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio in Older Patients with Metastatic Colorectal Cancer. Journal of Geriatric Oncology, 10, 742-748. https://doi.org/10.1016/j.jgo.2018.10.002
|
[41]
|
Zhou, X., Xu, L., Huang, Z., Zhang, L., Zhang, H., Zhu, W. and Liu, P. (2016) The Hematologic Markers as Prognostic Factors in Patients with Resectable Gastric Cancer. Cancer Biomarkers, 17, 359-367. https://doi.org/10.3233/CBM-160648
|
[42]
|
Essager, M., Neofytou, K., Chaudry, M.A. and Allum, W.H. (2015) Prognostic Impact of Preoperative Platelets to Lymphocytes Ratio (PLR) on Survival for Oesophageal and Junctional Carcinoma Treated with Neoadjuvant Chemotherapy: A Retrospective Monocentric Study on 153 Patients. European Journal of Surgical Oncology, 41, 1316-1323. https://doi.org/10.1016/j.ejso.2015.06.007
|
[43]
|
Yoon, H.-J., Kim, B.S., Moon, C.M., Yoo, J., Lee, K.E. and Kim, Y. (2018) Prognostic Value of Diffuse Splenic FDG Uptake on PET/CT in Patients with Gastric Cancer. PLOS ONE, 13, e0196110. https://doi.org/10.1371/journal.pone.0196110
|
[44]
|
Urabe, M., Yamashita, H., Watanabe, T. and Seto, Y. (2018) Comparison of Prognostic Abilities among Preoperative Laboratory Data Indices in Patients with Resectable Gastric and Esophagogastric Junction Adenocarcinoma. World Journal of Surgery, 42, 185-194. https://doi.org/10.1007/s00268-017-4146-9
|
[45]
|
Lian, L., Xia, Y.-Y., Zhou, C., Shen, X.-M., Li, X.-L., Han, S.-G., Zheng, Y., Mao, Z.-Q., Gong, F.-R., Wu, M.-Y., et al. (2015) Application of Platelet/Lymphocyte and Neutrophil/Lymphocyte Ratios in Early Diagnosis and Prognostic Prediction in Patients with Resectable Gastric Cancer. Cancer Biomarkers, 15, 899-907. https://doi.org/10.3233/CBM-150534
|
[46]
|
Hu, B., Yang, X.-R., Xu, Y., et al. (2014) Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular Carcinoma. Clinical Cancer Research, 20, 6212-6222. https://doi.org/10.1158/1078-0432.CCR-14-0442
|
[47]
|
Wang, K., Diao, F., Ye, Z., et al. (2017) Prognostic Value of Systemic Immune-Inflammation Index in Patients with Gastric Cancer. Chinese Journal of Cancer, 36, Article No. 75. https://doi.org/10.1186/s40880-017-0243-2
|
[48]
|
张宇, 汪亦民, 薛英威. 全身免疫炎症指数(SII)与胃癌患者临床病理因素及预后的相关性[J]. 现代肿瘤医学, 2021, 29(3): 441-445.
|
[49]
|
Hirahara, N., Tajima, Y., Matsubara, T., et al. (2021) Systemic Immune-Inflammation Index Predicts Overall Survival in Patients with Gastric Cancer: A Propensity Score-Matched Analysis. Journal of Gastrointestinal Surgery, 25, 1124-1133. https://doi.org/10.1007/s11605-020-04710-7
|
[50]
|
Wang, D., Hu, X., Xiao, L., et al. (2021) Prognostic Nutritional Index and Systemic Immune-Inflammation Index Predict the Prognosis of Patients with HCC. Journal of Gastrointestinal Surgery, 25, 421-427. https://doi.org/10.1007/s11605-019-04492-7
|
[51]
|
Chen, J.-H., Zhai, E.-T., Yuan, Y.-J., et al. (2017) Systemic Immune-Inflammation Index for Predicting Prognosis of Colorectal Cancer. World Journal of Gastroenterology, 23, 6261-6272. https://doi.org/10.3748/wjg.v23.i34.6261
|